EQT Partners acquired a majority stake in London specialty broker McGill and Partners from Warburg Pincus for $2 billion, the latest in a string of nine-figure insurance distribution deals that show no signs of cooling despite broader buyout market compression. The transaction closed this week, the same seven-day window in which KKR exited USI Insurance Services for a reported $17 billion.
McGill and Partners, founded in 2021 by former Jardine Lloyd Thompson executives, operates as a Lloyd's of London specialist focused on complex commercial risks and reinsurance placement. The firm generated approximately $400 million in revenue over the trailing twelve months, implying EQT paid roughly 5x revenue for a broker with minimal tangible assets and high people risk. Warburg Pincus originally backed the management team's spinout with a reported $500 million commitment, exiting at an estimated 4x cash multiple in under four years.
The deal underscores two structural themes in insurance M&A. First, specialty brokerage multiples have held steady at 12-15x EBITDA even as software and industrials repriced downward through 2024. Distribution businesses with recurring commission streams and low capital intensity trade closer to asset managers than services firms. Second, the insurance rate hardening cycle that began in 2018 has extended through multiple predicted inflection points, keeping revenue growth rates for well-positioned brokers in the mid-teens annually without corresponding expense growth. For PE buyers, that combination—predictable cash conversion, minimal reinvestment needs, and a tailwind from carrier pricing discipline—creates a rare environment where leverage works and operational complexity remains bounded.
EQT already owns Howden Group, a global specialty broker it acquired from Centerbridge and CDPQ in 2020 for $1.8 billion and has since scaled to over $1 billion in revenue. The McGill combination positions EQT to run a dual-brand strategy: Howden for wholesale and facultative reinsurance, McGill for Lloyd's-centric placements and high-net-worth complex risks. The synergy case is thin—these are relationship businesses where brand dilution is a real risk—but the portfolio revenue concentration improves EQT's ability to negotiate retrocession capacity and access Lloyd's syndicate capital on preferential terms.
Allocators should track whether EQT holds both platforms separately through exit or attempts a merger within eighteen months, which would signal confidence in cross-sell execution versus a pure multiple arbitrage thesis. Specialty broker M&A has historically destroyed value when acquirers force integration on producer teams; the Aon-NFP rollup in the 2000s and Marsh's over-integration of JLT are the cautionary templates. Watch for McGill's founding partners to either increase their equity stakes in the combined entity or quietly begin non-competes that expire in 2028, both of which would clarify how EQT is actually managing retention risk.
The $19 billion combined enterprise value across McGill and USI in a single week matches the total insurance services M&A volume for all of 2022, and follows Blackstone's $13 billion take-private of Aon's reinsurance arm earlier this year. Specialty brokerage now sits alongside life settlements and third-party administrators as the three insurance subsectors where LP capital commitments are accelerating, not plateauing, into 2025.